MRI, magnetic resonance imaging; NEDA, no evidence of disease activity. **p < 0.01; ****p < 0.0001 for peginterferon beta-1a every 2 weeks vs placebo; † p < 0.05; † † † † p < 0.0001 for peginterferon beta-1a every 2 weeks vs peginterferon beta-1a every 4 weeks (comparison was not conducted at year 1). Three patients from the total population did not have MRI information and were not assessable for overall NEDA+/NEDA− status; therefore, the sum of the NEDA+ (n = 196) and NEDA− (n = 877) subpopulations is equal to 1073.
Supplemental
EDSS, Expanded Disability Status Scale; MRI, magnetic resonance imaging; NEDA, no evidence of disease activity; NEDA+, achieved overall NEDA in ADVANCE; NEDA−, did not achieve overall NEDA in ADVANCE; SD, standard deviation.
